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Magnesium concentration was measured in the right atrial ap· 
pendage of 100 patients undergoing cardiac surgery and associa· 
tions with serum and mononuclear blood cell magnesium, other 
laboratory values and patient clinical variables were studied. In 
addition, magnesium was measured in the right atrial appendage 
and left ventricular free wall in 23 autopsy subjects to determine 
whether there was a proportional relation between right atrial 
appendage and left ventricular free wall magnesium. 
The mean left ventricular free wall/right atrial appendage 
magnesium ratio was 2.13 ± 0.39 (r = 0.67, p = 0.0009). In the 
group with cardiac surgery, the right atrial appendage magne· 
sium concentration correlated inversely with age (r = -0.54, P = 
0.001). The mean right atrial appendage magnesium concentra· 
tion (p.g/g wet weight tissue) was lower in patients with postoper· 
ative cardiac arrhythmia than in those without arrhythmia (103 ± 
13 versus 111 ± 10, p = 0.009) and in diabetic than in nondiabetic 
Hypomagnesemia is a common electrolyte disorder in hos-
pitalized patients, particularly those entering the intensive 
care unit (1,2). Many clinical signs. symptoms and disease 
states are attributed to altered magnesium homeostasis (3-
5). Measurement of the concentration of magnesium in 
serum is generally used to detect magnesium deficiency even 
though only 1 % of the total body content of magnesium is 
present in the serum and most magnesium is contained in the 
bone and soft tissue. 
Measurement of intracellular magnesium may have ad-
vantages over serum determination in detecting abnormali-
ties of magnesium homeostasis in patients (6.7). However. it 
is not clear which cell popUlation best reflects overall mag-
nesium status because metabolic activity and intracellular 
constituents vary among different cell types. Measurement 
of magnesium in mononuclear blood cells, metabolically 
active cells, has potential for clinical application because of 
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patients (103 ± 13 versus 109 ± 12, P = 0.02). The right atrial 
appendage magnesium concentration also tended to be lower in 
patients receiving potassium/magnesium.losing diuretics, al· 
though this difference did not achieve statistical significance 
(lOS ± 14 versus 109 ± 11, P = 0.16). 
Right atrial appendage magnesium concentration correlated 
positively with serum creatinine concentration (r = 0.31, p = 
0.002) and negatively with serum calcium concentration (r = 
-0.29, P = 0.013). Serum magnesium did not correlate with right 
atrial appendage or mononuclear blood cell magnesium concen· 
tration or clinical variables. There was a statistically significant 
correlation between mononuclear blood cell and right atrial 
appendage magnesium concentrations in some subgroups of pa· 
tients. 
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the ease of obtaining the specimen and performing the assay 
(8.9). 
The purpose of this study was to measure the magnesium 
concentration in the right atrial appendage of patients under-
going cardiac surgery and to determine the association of 
this measurement with the magnesium concentration in 
serum and mononuclear blood cells. other routine laboratory 
values and clinical variables. Additionally. magnesium was 
measured in the right atrial appendage and left ventricular 
free wall in a series of autopsy subjects to determine whether 
there was a relation between the magnesium concentrations 
in these two areas of the heart. 
Methods 
Autopsy cases. For the autopsy portion of this study, 23 
autopsy cases were used. Selection of autopsy cases was 
based on the timeliness of the autopsy. The autopsies (and 
cardiac surgery) were performed at St. Joseph's Hospital in 
Marshfield. Wisconsin. a 500 bed community referral hospi-
tal located in central Wisconsin and physically connected to 
the Marshfield Clinic. an approximately 350 physician mul-
tispecialty clinic. The autopsy subjects died of a variety of 
acute and chronic illnesses including chronic and acute renal 
failure. various types of cancer. acute myocardial infarction, 
chronic and acute respiratory failure, hepatic failure. diabe-
0735-1097/91/$3.50 
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tes mellitus, congestive heart failure and pulmonary em-
bolism. They had been taking a variety of medications 
including diuretics, insulin, oral hypoglycemic agents, anti-
neoplastic agents and antihypertensive drugs and had wide 
variation in laboratory values. 
Cardiac surgery patients. One hundred patients undergo-
ing cardiac surgery between March 1988 and September 1989 
who were willing to participate were selected after signed 
informed consent was obtained. This study was approved by 
the Institutional Review Board on Human Research of 
Marshfield Clinic. The only exclusion criterion was previous 
cardiac surgery because these patients were likely to have 
had the right atrial appendage removed at the previous 
surgery. The majority of these patients were undergoing 
elective coronary artery bypass grafting; the remainder were 
undergoing valve replacement for acquired valvular heart 
disease. 
Autopsy group tissue sampling and protocol. The right 
atrial appendage and a portion of grossly appearing left 
ventricular free wall were sampled within 12 h of death. The 
tissue was transported in magnesium-free containers and 
processed within 2 h. The charts of these patients were then 
reviewed for the following information: age, sex, diagnoses, 
cause of death, duration of illness, medications at the time of 
death and available laboratory data. 
Cardiac surgery group blood and tissue sampling and 
protocol. Blood was sampled the morning before surgery 
and analyzed for routine preoperative laboratory tests (urea 
nitrogen [BUN], electrolytes, total protein, albumin, glucose 
and calcium). Preoperative cardiac rhythm was obtained 
from the 12 lead electrocardiogram (ECG). Cardiac cathe-
terization was done within 2 weeks before surgery. Serum 
creatine kinase isoenzyme was determined every 8 h for 48 h 
after surgery. 
The day of surgery, before the induction of general 
anesthesia, 30 ml of blood was withdrawn from the previ-
ously inserted central venous line for analysis of mononu-
clear blood cell and serum magnesium. After induction of 
general anesthesia (before the institution of cardiopulmonary 
bypass) during venous cannulation through the right atrial 
appendage, a segment of the right atrial appendage was 
sampled. The blood and tissue samples were transported in 
magnesium-free containers and processed within 2 h of 
collection. 
Without knowledge of the magnesium results, charts 
were reviewed for the following information: age, gender, 
diagnoses, reason for cardiac surgery, medications at the 
time of surgery, preoperative laboratory values, preopera-
tive left ventricular ejection fraction determined at the time 
of cardiac catheterization and peak postoperative creatine 
kinase isoenzyme. 
Postoperative arrhythmia status was determined by clas-
sifying patients as having postoperative arrhythmia if they 
had no preoperative arrhythmia and had supraventricular 
tachycardia, ventricular tachycardia or ventricular fibrilla-
tion, or both, requiring treatment during their postoperative 
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course. The preoperative clinical status of patients was 
determined retrospectively by chart review without knowl-
edge of magnesium results. A patient was classified into the 
"normal" group if he or she had coronary artery disease as 
the only diagnosis, normal renal function, preoperative left 
ventricular ejection fraction ~50%, no preoperative diuretic 
use, no preoperative arrhythmia and preoperative laboratory 
values within the reference range. The remaining patients 
were classified as "abnormal." 
Patients were classified as having diabetes mellitus if 
they had a fasting blood sugar > 150 mg/dl, a history of 
hypoglycemic agent use or a previous diagnosis of diabetes 
mellitus. Patients were classified in the "diuretic use" cate-
gory if they had taken any potassium/magnesium-losing 
diuretic continuously during the preceding 4 weeks. 
Myocardial magnesium assay. Myocardial tissue was ini-
tially prepared by removing all visible fat and connective 
tissue and blotted free of fluid. Each specimen was then 
divided into two or three roughly equal sections and weighed 
on an analytical scale. Each section was then placed in a 
separate magnesium-free plastic conical tube (Corning Glass 
Works) to which 0.25 ml concentrated nitric acid was added. 
These tubes were then capped and incubated for 4 h in a 
water bath at 80°C. After digestion, 2.25 ml of 0.9% sodium 
chloride was added and the sample frozen. This wet-ashing 
method produced a clear solution appropriate for standard 
instrument conditions used for flame atomic absorption 
spectrophotometry when approximately 100 to 200 mg of 
tissue was used in each digestion. The final magnesium 
concentration was reported as the weighted average of 
individual sections. The standards were matrix-matched for 
sodium. 
Reagents and equipment were screened for magnesium 
contamination by periodically performing all processing 
steps without adding the cardiac tissue. Magnesium mea-
surement was then performed on this solution. With the 
equipment and reagents used, no significant magnesium 
contamination was found. 
Magnesium measurements were made in batches on the 
digestates after dilution (I :40) with 0.5% lanthanum chloride. 
All magnesium determinations were performed on a flame 
atomic absorption spectrophotometer (Perkin Elmer, model 
306). Units for reporting myocardial magnesium concentra-
tions were micrograms of magnesium/gram of wet weight 
tissue. All mononuclear blood cell determinations were 
performed as previously described by our center (8) and 
reported as content (femtograms of magnesium/cell). 
To assess the precision of our myocardial magnesium 
assay, we obtained large samples of tissue from the right 
atrial appendage and left ventricular free wall of one autopsy 
subject. These were divided into 10 (right atrial appendage) 
and 6 (left ventricular free wall) roughly equal sections and 
frozen. On separate days the samples were thawed, wet-
ashed and assayed for magnesium. For the right atrial 
appendage the coefficient of variation ([SD/mean] x 100) 
was 4.8% and for the left ventricular free wall, 2.4%. 
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Figure 1. Relation between right atrial appendage and left ventric-
ular free wall magnesium concentration in 23 autopsy cases. 
Statistical analysis. Mean and SD values were reported 
for separate groups. For determination of statistical signifi-
cance of differences in means between two independent 
groups, Student's t test was used. For differences in means 
between multiple groups, one-way analysis of variance was 
used. To test ihe effect of independent variables on contin-
uous measures, multiple linear regression was used. To 
adjust for the effect of independent variables on dichoto-
mous classification variables, logistic regression was used. 
For correlations between variables. Pearson's product mo-
ment correlation coefficient was used. Probability (p) values 
were two-tailed. The value for N varies because not all 
patients had all routine laboratory values measured. Statis-
tical analysis were performed using SPSS/PC+ software 
(SPSS, Inc.) run on an IBM-compatible microcomputer. 
Results 
Autopsy group. There were 23 autopsy subjects (16 men, 
7 women) with a mean age of 65.9 ± 14.9. The magnesium 
concentration for right atrial appendage was 85 ± 20 and for 
left ventricular free wall 179 ± 41 /Lg/g wet-weight tissue 
(Fi~. 1). The mean ratio of left ventricular free wall/right 
atnal appendage magnesium concentrations was 2.13 ± 0.39. 
There was no correlation between age and myocardial 
magnesium concentration in this group. 
Table 1. Relation of Myocardial Magnesium to Age in 100 
Surgically Treated Patients 
Age Group (yr) n Myocardial Magnesium' 
::;49 6 117 :!: 12 (p = 0.03)t 
50-64 43 109:!: 14 
65 to 74 37 106:!: II 
?!75 14 100 :!: 12 
'/Lg magnesium/g wet tissue; ttwo-tail probability using one-way analysis 
of variance (ANOV A). 
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Table 2. Relation of Myocardial Magnesium to Overall 
Clinical Status 
653 
n Age (yr) Myocardial Magnesium' 
Normal 38 62.5 :!: 10.4 112 :!: 9 
Abnormal 61 66.1 :!: 9.5 lOS:!: 13 
pt 0.08 0.01 
'/Lgig wet -weight; ttwo-tail probability using multiple regression with 
independent variables of age and normal/abnormal status where normal 
s~bje~ts are patients who have coronary artery disease only, are not taking 
dlUrettcs and have a left ventricular ejection fraction ?!0.50 and a serum 
creatinine level ::;1.5 mg/dl; abnormal subjects are the remaining patients 
(treated hypertension. diabetes mellitus, receiving diuretics, a serum creati-
nine level> 1.5 mgidl or a left ventricular ejection fraction <0.50). 
Cardiac surgery group. Of the 100 cardiac surgery pa-
tients, there were 74 men and 26 women with a mean age of 
63.2 ± 10.6 and 69.0 ± 5.7, respectively (p = 0.01). For men, 
the right atrial appendage magnesium concentration was 
108 ± 14 and for women 105 ± 11 ~g/g wet weight tissue (p = 
0.8, adjusting for age using mUltiple linear regression). The 
association between age and myocardial magnesium concen-
tration is shown in Table 1. 
When the patients were classified into normal and abnor-
mal groups, a significant difference was found in myocardial 
magnesium concentrations (Table 2). When the normal 
group was further analyzed for the association between age 
and myocardial magnesium concentration, a stronger corre-
lation (r = -0.54, p = 0.001) was found than in the overall 
group. 
There was a significant difference in myocardial magne-
sium concentration between patient groups with and without 
postoperative cardiac arrhythmia (Table 3). This difference 
remained significant when age and variables known to be 
associated with arrhythmia (postoperative peak creatine 
kinase isoenzyme, preoperative left ventricular ejection frac-
tion and serum potassium concentration) were also included 
as independent variables in logistic regression. 
The association of other clinical variables with myocar-
dial magnesium is shown in Table 4. The only variable 
associated with a significant difference in myocardial mag-
nesium concentration was diabetes mellitus. The use of 
diuretics was not associated with a significant difference in 
Table 3. Relation of Myocardial Magnesium to 
Postoperative Arrhythmia 
No. Age (yr) Myocardial Magnesium' 
No arrhythmiat 52 62.3 :!: 10.2 III :!: 10 
Arrhythmia 47 67.4:!:9.1 103:!: 13 
p value:j: 0.009 0.0001 
p value§ 0.46 0.009 
'~gig wet-weight; tarrhythmia is defined as supraventricular tachycardia, 
ventrIcular tachycardia or ventricular fibrillation requiring treatment; :j:two-
tail probability using unpaired t test; §two-tail probability using logistic 
regression with age. myocardial magnesium. left ventricular ejection fraction. 
serum potassium and postoperative creatine kinase isoenzyme as independent 
variables. 
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Table 4. Relation of Myocardial Magnesium to Other Clinical Variables 
Myocardial Myocardial 
Magnesium Magnesium 
Clinical Variable n With Variable' n Without Variable' p valuet 
Diabetes mellitus 24 103 ± 13 75 109 ± 12 0.02 
Diuretic 26 105 ± 14 74 109 ± 11 0.16 
Congestive failure 6 110 ± 14 93 107 ± 12 NS 
Digoxin 15 108 ± 13 84 107 ± 12 NS 
ACE inhibitor 14 107 ± 14 85 107 ± 12 NS 
Calcium channel blocker 56 106 ± 12 43 109 ± 13 NS 
Beta-adrenergic blocker 37 107 ± 12 62 108 ± 12 NS 
'JLg/g wet weight; ttwo-tail probability using t test (associations or lack thereof confirmed with analysis of covariance adjusting for the effects of age). ACE = 
angiotensin-converting enzyme; the diuretic used was furosemide, hydrochlorothiazide or indapamide. 
myocardial magnesium from that of the nondiuretic group, 
although the diuretic group tended to have lower myocardial 
magnesium concentrations. 
Myocardial magnesium was positively correlated with the 
serum creatinine concentration (r = 0.31, P = 0.002) and 
negatively correlated with the serum calcium concentration 
(r = -0.29, p = 0.013). The associations between myocar-
dial, serum and mononuclear blood cell magnesium concen-
trations in the total group and various subgroups of patients 
are shown in Table 5. 
Discussion 
Autopsy Cases 
Myocardial magnesium concentration can be measured 
reproducibly using commonly available equipment and re-
agents. Our results for mean left ventricular free wall mag-
Table 5. Association of Myocardial, Mononuclear Blood Cell and 
Serum Magnesium 
Group 
All patients (n = 100) 
p 
Abnormal subjects 
(n = 61) 
p 
Patients with postoperative 
arrhythmia (n = 47) 
p 
Diuretic users (n = 26) 
p 
Diabetic patients (n = 24) 
p 
Myocardial Versus 
Mononuclear 
Blood Cell 
Magnesium 
0.10 
0.34 
0.26 
0.045 
0.25 
0.09 
0.31 
0.12 
0.32 
0.13 
Myocardial Versus 
Serum Magnesium 
0.02 
0.87 
-0.08 
0.54 
-0.11 
0.47 
-0.15 
0.47 
-0.004 
0.99 
p = two-tail probability; r = Pearson's product moment correlation 
coefficient. 
nesium concentration in autopsy cases were comparable 
with those of other studies performed on postmortem spec-
imens (10-15) and the mean magnesium concentration of 
right atrial appendage of our patients undergoing cardiac 
surgery was similar to that of another series (16) (Table 6). 
The right atrial appendage magnesium concentration 
was significantly lower in our autopsy subjects than in our 
cardiac surgery patients. This difference was probably re-
lated to the more severe and long-standing illnesses of the 
autopsy subjects. 
Left ventricular free wall versus left atrial appendage. The 
myocardial magnesium concentration of the left ventricular 
free wall was approximately twice that of the right atrial 
appendage (mean ratio 2.13). Clinically significant arrhyth-
mias arise in both the atria and the ventricles. Because in the 
cardiac surgery group we measured only the right atrial 
appendage magnesium concentration, we attempted to de-
termine from our autopsy series whether the magnesium 
concentration in the right atrial appendage was predictive of 
left ventricular free wall magnesium concentration. This 
Table 6. Comparison of Myocardial Magnesium Concentrations 
Among Previous Studies 
Right Atrial Left Ventricular 
Study (first author) Appendage' Free Wall' 
Reinhart (present study) 
Cadaver 85 ± 20 179 ± 41 
Patient (overall) 107 ± 13 
Patient ("Norma''') 112 ± 9 
Oster (16) 
Patient (coronary 112 ± 32 
artery disease) 
Johnson (10) 
Cadaver (ischemic 194 ± 38 
heart disease) 
Elwood (1 \) 
n 
23 
100 
38 
27 
14 
Cadaver (ischemic 177 ± 32 611 
heart disease) 
Chipperfield (12) 
Cadaver (ischemic 173 ± 17 22 
heart disease) 
'Micrograms of magnesiumig wet weight tissue. 
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proportional relation was present for the range of concentra-
tions measured and the variety of disease states present in 
our autopsy subjects. 
We postulate that magnesium concentration is higher in 
the left ventricular free wall than in the right atrial appendage 
because of the structural and functional differences between 
the two cardiac chambers (17). The majority of intracellular 
magnesium is complexed to adenine nucleotides and within 
mitochondria (18). We postulate that because mitochondria 
(19) and adenine nucleotides are present in lower concentra-
tion in the right atrial appendage, magnesium is correspond-
ingly lower. 
Cardiac Surgery Cases 
Relation to age. The magnesium concentration in the 
right atrial appendage was inversely related to the age of the 
patient. A similar trend was found in another series (11). The 
relation of myocardial magnesium to age was stronger in our 
normal than in our abnormal patient group. Drugs and 
disease states that alter magnesium homeostasis are pre-
sumed to have a tendency to blunt the effect of age on 
myocardial magnesium concentration. It is not certain why 
magnesium concentration would decrease with age, but this 
phenomenon may be related to decrease of mitochondrial 
respiratory activity (20) and increase in myocardial collagen 
(21) associated with senescence. 
Normal versus abnormal group. The normal subgroup of 
patients had a significantly higher myocardial magnesium 
concentration than did the abnormal subgroup. This classi-
fication was arbitrary because no truly normal people under-
went cardiac surgery. Patients with factors, other than 
coronary artery disease (11,12), known to be associated with 
altered magnesium homeostasis were excluded from the 
normal group to allow for closer estimation of the reference 
range (94 to 130 [mean ± 2 SD] /J-g/g wet tissue) for 
magnesium concentration in the right atrial appendage. 
Another drawback to our arbitrary normal classification is 
the known association of coronary artery disease with lower 
myocardial magnesium concentration (10,12,13). 
Postoperative arrhythmia. Lower myocardial magnesium 
concentration was found when patients with postoperative 
arrhythmia were compared with those without arrhythmia. 
This difference remained significant by logistic regression 
analysis after adjustment for age and other factors known to 
be associated with arrhythmia (left ventricular ejection frac-
tion, serum potassium concentration and postoperative cre-
atine kinase isoenzyme). Hypomagnesemia has been shown 
in previous studies to be associated with atrial (22-25) and 
ventricular (26-28) arrhythmias, although the mechanism for 
this relation has not been elucidated. We postulate that low 
myocardial magnesium concentration played a causal role in 
the development of cardiac arrhythmias in our patients. It is 
not clear why this subgroup of patients had lower myocardial 
magnesium concentrations because the two groups were 
otherwise comparable. 
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Congestive heart failure. Myocardial magnesium is re-
ported to be lower in patients with congestive heart failure 
(29). We did not find this in our group of patients, probably 
because of the small number of patients with this problem 
and the unique nature of our study group in that few patients 
with a history of congestive heart failure underwent cardiac 
surgery. 
Renal function. There was a positive correlation between 
serum creatinine concentration and myocardial magnesium 
concentration. This relation was present within the reference 
range for creatinine. Because magnesium excretion is con-
trolled predominantly by renal mechanisms (30), overall 
renal function, as measured by these laboratory values, may 
be proportional to magnesium excretion (or retention) and 
result in different tissue concentrations. 
Diabetes. Diabetic patients have previously been demon-
strated (31) to have altered magnesium homeostasis, includ-
ing reduced skeletal muscle, but normal mononuclear blood 
cell magnesium concentration. Our diabetic subjects had 
significantly less myocardial magnesium than had nondia-
betic patients after values were adjusted for serum creatinine 
concentration and age by multiple linear regression analysis. 
Despite their lower myocardial magnesium concentration, 
diabetic patients were not significantly more prone to post-
operative cardiac arrhythmias as assessed by multiple re-
gression analysis. Other clinical variables observed in our 
patients were not associated with myocardial magnesium 
concentration, although those patients taking diuretic drugs 
tended to have lower concentrations. Beta-adrenergic block-
ers, calcium channel blockers and digoxin appeared to have 
no effect on myocardial magnesium concentrations. 
Mononuclear blood cells versus myocardial magnesium 
concentration. Mononuclear blood cell magnesium content 
correlated, albeit weakly, with myocardial magnesium con-
centration in some of our patient subgroups. The mononu-
clear blood cell is a metabolically active tissue but its 
intracellular constituents differ from those found in myocar-
dium. This fact, along with the measurement error inherent 
in both assays, could tend to weaken this correlation. The 
assays in this study measured the total magnesium concen-
trations. Measurement of the ionized or free magnesium, 
that component which is considered to be biologically active 
(32), may have resulted in a more significant correlation 
between the tissues. In contrast, the serum magnesium 
concentration was not correlated with myocardial magne-
sium, mononuclear blood cell magnesium or any clinical 
variable. 
Calcium versus magnesium concentration. There is a re-
lation between calcium and magnesium. Hypomagnesemia is 
associated with hypocalcemia. This association is multifac-
torial and is related to the effect of magnesium on parathy-
roid hormone synthesis, secretion and end-organ respon-
siveness (33,34). Additionally, magnesium deficiency is 
associated with an increased tissue concentration of calcium 
in animal models (35). In our study there was an inverse 
relation between serum calcium and myocardial magnesium 
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concentration that was independent of age, other electro-
lytes, renal function and serum magnesium concentration. 
Hypothesis to be tested. Our results suggest that the 
following hypothesis should be tested in future studies: 
administration of magnesium preoperatively to patients un-
dergoing cardiac surgery results in increased myocardial 
magnesium concentration or reduction in the incidence of 
postoperative cardiac arrhythmia, or both. Because cellular 
exchange of magnesium is relatively slow (unpublished 
observation), these effects would occur only if magnesium 
was administered for several days to weeks before surgery. 
Clinical implications. Because there may be a causal 
relation between lower myocardial magnesium concentra-
tion and postoperative cardiac arrhythmias, magnesium sup-
plementation, preoperatively and postoperatively, should be 
considered in patients undergoing cardiac surgery. This 
would need to be done on an empiric basis because the 
traditional method of assessing the magnesium status of a 
patient, that is, serum magnesium concentration measure-
ment, is not predictive of the myocardial magnesium con-
centration or occurrence of postoperative cardiac arrhyth-
mia. Laboratory values, such as mononuclear blood cell 
magnesium content and serum creatinine and calcium con-
centrations, as well as clinical variables such as age, diabetic 
status and diuretic use, may be of some value in predicting 
the magnesium status of a patient. 
We acknowledge Susan Spencer and Peter Rae for technical assistance, Meg 
Yaeger for data collection. Lauri Sommer for assistance in the cardiology 
practice, Steve Booher for specimen handling and Alice Stargardt for manu· 
script preparation. 
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